mrTRG assessment clinical trials

Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial

This study looks at a new way to check how well rectal cancer treatment works using special MRI scans. It aims to see if some patients can avoid surgery and instead be carefully watched, improving their quality of life.